86 related articles for article (PubMed ID: 25714671)
1. Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology.
Capuani B; Della-Morte D; Donadel G; Caratelli S; Bova L; Pastore D; De Canio M; D'Aguanno S; Coppola A; Pacifici F; Arriga R; Bellia A; Ferrelli F; Tesauro M; Federici M; Neri A; Bernardini S; Sbraccia P; Di Daniele N; Sconocchia G; Orlandi A; Urbani A; Lauro D
Am J Physiol Endocrinol Metab; 2015 May; 308(9):E744-55. PubMed ID: 25714671
[TBL] [Abstract][Full Text] [Related]
2. Proteomic and bioinformatic analysis of membrane proteome in type 2 diabetic mouse liver.
Kim GH; Park EC; Yun SH; Hong Y; Lee DG; Shin EY; Jung J; Kim YH; Lee KB; Jang IS; Lee ZW; Chung YH; Choi JS; Cheong C; Kim S; Kim SI
Proteomics; 2013 Apr; 13(7):1164-79. PubMed ID: 23349036
[TBL] [Abstract][Full Text] [Related]
3. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
4. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity.
Kubota N; Kubota T; Kajiwara E; Iwamura T; Kumagai H; Watanabe T; Inoue M; Takamoto I; Sasako T; Kumagai K; Kohjima M; Nakamuta M; Moroi M; Sugi K; Noda T; Terauchi Y; Ueki K; Kadowaki T
Nat Commun; 2016 Oct; 7():12977. PubMed ID: 27708333
[TBL] [Abstract][Full Text] [Related]
5. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
[TBL] [Abstract][Full Text] [Related]
6. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
[TBL] [Abstract][Full Text] [Related]
7. Extracting time-dependent obese-diabetic specific networks in hepatic proteome analysis.
Midha MK; Tikoo K; Sinha N; Kaur S; Verma HN; Rao KV; Chatterjee S; Manivel V
J Proteome Res; 2012 Dec; 11(12):6030-43. PubMed ID: 23050596
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.
Kido Y; Burks DJ; Withers D; Bruning JC; Kahn CR; White MF; Accili D
J Clin Invest; 2000 Jan; 105(2):199-205. PubMed ID: 10642598
[TBL] [Abstract][Full Text] [Related]
10. Improved metabolic disorders of insulin receptor-deficient mice by transgenic overexpression of glucokinase in the liver.
Jackerott M; Baudry A; Bucchini D; Jami J; Joshi RL
Diabetologia; 2002 Sep; 45(9):1292-7. PubMed ID: 12242462
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of propiconazole responses in mouse liver: comparison of genomic and proteomic profiles.
Ortiz PA; Bruno ME; Moore T; Nesnow S; Winnik W; Ge Y
J Proteome Res; 2010 Mar; 9(3):1268-78. PubMed ID: 20095644
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
[TBL] [Abstract][Full Text] [Related]
14. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
15. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
16. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA
Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419
[TBL] [Abstract][Full Text] [Related]
17. Role of fibroblast growth factor 19 in the control of glucose homeostasis.
Schaap FG
Curr Opin Clin Nutr Metab Care; 2012 Jul; 15(4):386-91. PubMed ID: 22617565
[TBL] [Abstract][Full Text] [Related]
18. Proteome analysis of fatty liver in feed-deprived dairy cows reveals interaction of fuel sensing, calcium, fatty acid, and glycogen metabolism.
Kuhla B; Albrecht D; Kuhla S; Metges CC
Physiol Genomics; 2009 Apr; 37(2):88-98. PubMed ID: 19240300
[TBL] [Abstract][Full Text] [Related]
19. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism.
Kim MH; Park JS; Jung JW; Byun KW; Kang KS; Lee YS
Int J Obes (Lond); 2011 Aug; 35(8):1019-30. PubMed ID: 21157426
[TBL] [Abstract][Full Text] [Related]
20. Altered insulin receptor messenger ribonucleic acid splicing in liver is associated with deterioration of glucose tolerance in the spontaneously obese and diabetic rhesus monkey: analysis of controversy between monkey and human studies.
Huang Z; Bodkin NL; Ortmeyer HK; Zenilman ME; Webster NJ; Hansen BC; Shuldiner AR
J Clin Endocrinol Metab; 1996 Apr; 81(4):1552-6. PubMed ID: 8636366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
